Aerovate Therapeutics, INC. (JBIO) SEC Filings — 2024

Filings

• Aerovate Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• Aerovate Therapeutics Q3 2024 Financial Update — 10-Q · Nov 12, 2024
• Aerovate Therapeutics to be Acquired by InspireMD — 8-K · Oct 31, 2024
• Aerovate Therapeutics Faces Delisting Concerns — 8-K · Oct 17, 2024
• Aerovate Therapeutics Announces Leadership Changes — 8-K · Oct 10, 2024
• Aerovate Therapeutics Reports Q2 2024 Results — 10-Q · Aug 12, 2024
• Aerovate Therapeutics Files 8-K — 8-K · Jul 8, 2024
• Aerovate Therapeutics Files Amendment on Exit Costs — 8-K/A · Jul 1, 2024
• Aerovate Therapeutics Reports Exit Costs — 8-K · Jun 28, 2024
• RA Capital Amends Stake in Aerovate Therapeutics — SC 13D/A · Jun 20, 2024
• Aerovate Therapeutics Terminates Merger with Hansoh Pharma — 8-K · Jun 17, 2024
• Aerovate Therapeutics Holds Shareholder Vote — 8-K · Jun 7, 2024
• Aerovate Therapeutics Files 8-K — 8-K · May 13, 2024
• Aerovate Therapeutics, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 13, 2024
• RA Capital Amends Aerovate Therapeutics Stake — SC 13D/A · Apr 30, 2024
• Aerovate Therapeutics Schedules 2024 Annual Meeting of Stockholders for June 5 — DEF 14A · Apr 26, 2024
• Aerovate Therapeutics Files 8-K Report — 8-K · Mar 27, 2024
• Aerovate Therapeutics, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 25, 2024
• Sofinnova Amends Aerovate Therapeutics Stake — SC 13D/A · Feb 20, 2024
• Aerovate Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• Aerovate Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• TCG Crossover GP I Takes 7.2% Stake in Aerovate Therapeutics — SC 13G · Feb 9, 2024
• Aerovate Therapeutics Files Routine 8-K on Jan 8, 2024 — 8-K · Jan 8, 2024